Ambipar Emerg Resp A (AMBIQ) Financials
Newest figures come from the filing for FY2024, filed Jun 24, 2025. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AMBIQ SEC filings page.
Ambipar Emerg Resp A (AMBIQ) reported $525.3M in revenue for fiscal year 2024, down 1.6% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 5 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings.
Financial Health Signals
We do not publish a peer-relative financial health score for Ambipar Emerg Resp A, because the score only covers companies whose filings and listing give us what it needs to compare them with their peers. The signals and metrics below are current.
Ambipar Emerg Resp A scores 0.98, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $13.4M against total assets of $937.9M. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.
Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.
Ambipar Emerg Resp A passes 4 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 3 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.
Ambipar Emerg Resp A reported a net loss of $3.3M while generating $68.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal.
Ambipar Emerg Resp A earns $6.85 in operating income for every $1 of interest expense ($78.6M vs $11.5M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.
Key Financial Metrics
Earnings & Revenue
Ambipar Emerg Resp A generated $525.3M in revenue in fiscal year 2024. This represents a decrease of 1.6% from the prior year.
Ambipar Emerg Resp A's EBITDA was $130.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 17.0% from the prior year.
Ambipar Emerg Resp A reported a net loss of $3.3M in fiscal year 2024. The change from the prior year is not meaningful, because that figure was zero or negative.
Ambipar Emerg Resp A earned $0.13 per diluted share (EPS) in fiscal year 2024. This represents an increase of 286.9% from the prior year.
Cash & Balance Sheet
Ambipar Emerg Resp A generated $50.4M in free cash flow in fiscal year 2024, representing cash available after capex. The change from the prior year is not meaningful, because that figure was zero or negative.
Ambipar Emerg Resp A held $58.0M in cash against $200.8M in long-term debt as of fiscal year 2024.
Not reported for fiscal year 2024.
Margins & Returns
Ambipar Emerg Resp A's gross margin was 14.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs. This is down 4.5 percentage points from the prior year.
Ambipar Emerg Resp A's operating margin was 14.9% in fiscal year 2024, reflecting core business profitability. This is up 1.0 percentage points from the prior year.
Ambipar Emerg Resp A's net profit margin was -0.6% in fiscal year 2024, showing the share of revenue converted to profit. This is up 1.8 percentage points from the prior year.
Ambipar Emerg Resp A's ROE was -1.4% in fiscal year 2024, measuring profit generated per dollar of shareholder equity. This is up 4.4 percentage points from the prior year.
Capital Allocation
Ambipar Emerg Resp A invested $17.8M in capex in fiscal year 2024, funding long-term assets and infrastructure. This represents a decrease of 63.5% from the prior year.
Not reported for fiscal year 2024.
Not reported for fiscal year 2024.
AMBIQ Income Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing |
|---|---|---|---|---|---|
| Revenue | $525.3M-1.6% | $533.8M+67.5% | $318.7M+116.1% | $147.5M+110.3% | $70.1M |
| Cost of Revenue | $447.9M+4.0% | $430.8M+70.2% | $253.1M+128.0% | $111.0M+125.0% | $49.3M |
| Gross Profit | $77.4M-24.8% | $102.9M+56.7% | $65.7M+79.9% | $36.5M+75.3% | $20.8M |
| Operating Income | $78.6M+5.8% | $74.3M+16.6% | $63.7M+99.5% | $31.9M+84.5% | $17.3M |
| EBITDA | $130.7M+17.0% | $111.8M+31.6% | $84.9M+98.7% | $42.7M+97.4% | $21.6M |
| Interest Expense | $11.5M+2.0% | $11.2M+117.4% | $5.2M+286.7% | $1.3M+80.5% | $741K |
| Income Tax | -$11.0Mn/m | -$18.9Mn/m | -$8.5Mn/m | -$6.8M-310.5% | $3.2M |
| Net Income | -$3.3Mn/m | -$12.9M-142.1% | $30.6M+29.9% | $23.5M+98.0% | $11.9M |
| EPS (Basic) | $0.17+335.0% | $0.04-71.0% | $0.14 | $0.51+47.9% | $0.34 |
| EPS (Diluted) | $0.13+286.9% | $0.03-74.7% | $0.14 | $0.51+47.9% | $0.34 |
| Diluted Shares (Avg) | N/A | N/A | N/A | 49M | N/A |
Not reported in any period shown, so not listed: R&D Expenses, SG&A Expenses.
AMBIQ Balance Sheet
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing |
|---|---|---|---|---|---|
| Total Assets | $937.9M+5.6% | $888.1M+36.8% | $649.0M+152.8% | $256.7M | N/A |
| Current Assets | $282.9M-4.7% | $296.8M+38.5% | $214.3M+163.5% | $81.3M | N/A |
| Cash & Equivalents | $58.0M-33.6% | $87.2M+69.8% | $51.4M+140.9% | $21.3M+79.4% | $11.9M |
| Inventory | $7.5M+6.4% | $7.0M+105.3% | $3.4M+117.7% | $1.6M | N/A |
| Accounts Receivable | $177.9M+7.4% | $165.6M+24.5% | $133.0M+216.4% | $42.0M | N/A |
| Goodwill | $291.7M-7.9% | $316.8M+40.5% | $225.6M+114.7% | $105.1M | N/A |
| Total Liabilities | $703.5M+15.6% | $608.5M+7.8% | $564.4M+184.8% | $198.2M | N/A |
| Current Liabilities | $158.2M-4.4% | $165.5M+22.0% | $135.6M+118.5% | $62.1M | N/A |
| Non-Current Liabilities | $486.0M+9.7% | $443.0M+3.3% | $428.8M+220.0% | $134.0M | N/A |
| Long-Term Debt | $200.8M-16.2% | $239.7M+1.3% | $236.6M+944.9% | $22.6M | N/A |
| Total Equity | $234.4M+6.0% | $221.2M+220.0% | $69.1M+18.2% | $58.5M-7.2% | $63.0M |
| Retained Earnings | -$13.4Mn/m | -$12.9Mn/m | $0-100.0% | $31.6M | N/A |
Not reported in any period shown, so not listed: Short-Term Investments, Long-Term Investments.
AMBIQ Cash Flow Statement
Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing |
|---|---|---|---|---|---|
| Operating Cash Flow | $68.1M+321.3% | $16.2M-81.8% | $89.1M+672.1% | $11.5M+84.4% | $6.3M |
| Depreciation & Amortization | $52.2M+39.1% | $37.5M+76.9% | $21.2M+96.4% | $10.8M+148.9% | $4.3M |
| Capital Expenditures | $17.8M-63.5% | $48.7M+90.6% | $25.5M+15.0% | $22.2M+424.2% | $4.2M |
| Free Cash Flow | $50.4Mn/m | -$32.5M-151.1% | $63.6Mn/m | -$10.7M-627.5% | $2.0M |
| Investing Cash Flow | -$21.8Mn/m | -$59.2Mn/m | -$249.9Mn/m | -$80.4Mn/m | -$22.7M |
| Financing Cash Flow | -$83.1M-196.7% | $86.0M-54.3% | $188.2M+142.1% | $77.7M+270.7% | $21.0M |
| Dividends Paid | $8.4M+27.0% | $6.6Mn/m | $0-100.0% | $11K | N/A |
Not reported in any period shown, so not listed: Stock-Based Compensation, Share Buybacks.
AMBIQ Financial Ratios
Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.
| Metric | FY24Filing | FY23Filing | FY22Filing | FY21Filing | FY20Filing |
|---|---|---|---|---|---|
| Gross Margin | 14.7%-4.5pp | 19.3%-1.3pp | 20.6%-4.2pp | 24.8%-4.9pp | 29.7% |
| Operating Margin | 14.9%+1.0pp | 13.9%-6.1pp | 20.0%-1.7pp | 21.6%-3.0pp | 24.7% |
| Net Margin | -0.6%+1.8pp | -2.4%-12.0pp | 9.6%-6.4pp | 16.0%-1.0pp | 16.9% |
| Return on Equity | -1.4%+4.4pp | -5.8%-50.0pp | 44.2%+4.0pp | 40.2%+21.4pp | 18.9% |
| Return on Assets | -0.4%+1.1pp | -1.5%-6.2pp | 4.7%-4.5pp | 9.2% | N/A |
| Current Ratio | 1.790.0x | 1.79+0.2x | 1.58+0.3x | 1.31 | N/A |
| Debt-to-Equity | 0.86-0.2x | 1.08-2.3x | 3.42+3.0x | 0.39 | N/A |
| Liabilities-to-Equity | 3.00+0.3x | 2.75-5.4x | 8.17+4.8x | 3.39 | N/A |
| Asset Turnover | 0.560.0x | 0.60+0.1x | 0.49-0.1x | 0.57 | N/A |
| FCF Margin | 9.6%+15.7pp | -6.1%-26.0pp | 19.9%+27.2pp | -7.2%-10.1pp | 2.9% |
Similar Companies
Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.
| Company | Fiscal year | Revenue | Net income | Net margin | Market cap | Health score |
|---|---|---|---|---|---|---|
| Ambipar Emerg Resp A AMBIQ | FY2024 | $525.3M | -$3.3M | -0.6% | $3.9M | — |
| OriginClear Inc OCLN | FY2025 | $6.8M | -$18.3M | N/A | $4.9M | — |
Where Ambipar Emerg Resp A Ranks
Frequently Asked Questions
Ambipar Emerg Resp A (AMBIQ) reported $525.3M in total revenue for fiscal year 2024. This represents a -1.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.
Ambipar Emerg Resp A (AMBIQ) revenue declined by 1.6% year-over-year, from $533.8M to $525.3M in fiscal year 2024.
No, Ambipar Emerg Resp A (AMBIQ) reported a net loss of $3.3M in fiscal year 2024, with a net profit margin of -0.6%.
Ambipar Emerg Resp A (AMBIQ) had EBITDA of $130.7M in fiscal year 2024, measuring earnings before interest, taxes, depreciation, and amortization.
As of fiscal year 2024, Ambipar Emerg Resp A (AMBIQ) had $58.0M in cash and equivalents against $200.8M in long-term debt.
Ambipar Emerg Resp A (AMBIQ) had a gross margin of 14.7% in fiscal year 2024, indicating the percentage of revenue retained after direct costs of goods sold.
Ambipar Emerg Resp A (AMBIQ) had an operating margin of 14.9% in fiscal year 2024, reflecting the profitability of core business operations before interest and taxes.
Ambipar Emerg Resp A (AMBIQ) had a net profit margin of -0.6% in fiscal year 2024, representing the share of revenue converted into profit after all expenses.
Ambipar Emerg Resp A (AMBIQ) has a return on equity of -1.4% for fiscal year 2024, measuring how efficiently the company generates profit from shareholder equity.
Ambipar Emerg Resp A (AMBIQ) generated $50.4M in free cash flow during fiscal year 2024. The change from the previous fiscal year is not meaningful, because that year’s figure was zero or negative. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.
Ambipar Emerg Resp A (AMBIQ) generated $68.1M in operating cash flow during fiscal year 2024, representing cash generated from core business activities.
Ambipar Emerg Resp A (AMBIQ) had $937.9M in total assets as of fiscal year 2024, including both current and long-term assets.
Ambipar Emerg Resp A (AMBIQ) invested $17.8M in capital expenditures during fiscal year 2024, funding long-term assets and infrastructure.
Ambipar Emerg Resp A (AMBIQ) had a current ratio of 1.79 as of fiscal year 2024, which is generally considered healthy.
Ambipar Emerg Resp A (AMBIQ) had a debt-to-equity ratio of 0.86 as of fiscal year 2024. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.
Ambipar Emerg Resp A (AMBIQ) had a liabilities-to-equity ratio of 3.00 as of fiscal year 2024, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.
Ambipar Emerg Resp A (AMBIQ) had a return on assets of -0.4% for fiscal year 2024, measuring how efficiently the company uses its assets to generate profit.
Ambipar Emerg Resp A (AMBIQ) has an Altman Z-Score of 0.98, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.
Ambipar Emerg Resp A (AMBIQ) has a Piotroski F-Score of 4 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.
Ambipar Emerg Resp A (AMBIQ) reported a net loss of $3.3M while generating $68.1M in operating cash flow. Operations generated cash despite the loss, but with no positive earnings behind it, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.
Ambipar Emerg Resp A (AMBIQ) has an interest coverage ratio of 6.85x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.